FDA Publishes Notice of Patent Infringement Complaint Filed Against Biosimilar Applicant

Summary

The FDA has published a notice that a biosimilar applicant has filed a complaint for patent infringement related to their biologics license application, and must now provide the HHS with notice of the complaint within 30 days.